Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2020 Earnings Conference Call March 4, 2021 8:45 AM ET Company Participants Pam Murphy - IR Bill Collier - President and CEO Gaston Picchio - Chief Development Officer Mike Sofia - Chief Scientific Officer Dave Hastings - CFO Conference Call Participants Ed Arce - H.C. Wainwright Brian Skorney - Robert W. Baird Mayank Mamtani - B. Riley Kelechi Chikere - Jefferies Roy Buchanan - JMP Securities Keay Nakae - Chardan Operator Ladies and gentlemen, thank you for st ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-34949 ARBUTUS BIOPHARMA CORPORATION (Exact Name of Registrant as Specified in Its Charter) British Columbia, Canada 98-0597776 (State ...

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2020 Earnings Conference Call November 5, 2020 8:45 AM ET Company Participants Pam Murphy - Investor Relations Bill Collier - President & Chief Executive Officer Dave Hastings - Chief Financial Officer Gaston Picchio - Chief Development Officer Mike Sofia - Chief Scientific Officer Conference Call Participants Mayank Mamtani - B. Riley Roy Buchanan - JMP Securities Operator Ladies and gentlemen, thank you for standing by and welcome to Arbutus Biopharma Corpora ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-34949 ARBUTUS BIOPHARMA CORPORATION (Exact Name of Registrant as Specified in Its Charter) British Columbia, Canada (State or Other Jurisdi ...

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2020 Earnings Conference Call August 7, 2020 8:45 AM ET Company Representatives Bill Collier - President, Chief Executive Officer Mike Sofia - Chief Scientific Officer Gaston Picchio - Chief Development Officer Dave Hastings - Chief Financial Officer Pam Murphy - Investor Relations Conference Call Participants Mayank Mamtani - B. Riley Roy Buchanan - JMP Securities Operator Ladies and gentlemen, thank you for standing by and welcome to the Arbutus Biopharma Cor ...